Search

everythinglearnresearchcommunity

for

Search:↓

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

The document concludes that skin and nail changes can indicate various underlying health conditions.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

COVID-19 may harm male fertility and damage the reproductive system.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

A man with rare skin changes on his fingers was diagnosed with multiple myeloma-linked amyloidosis.

Using electronic health records can help identify drug side effects but has some limitations.

Older men with late-onset lupus have a higher mortality rate than women.

The study aims to create a model to improve personalized and preventive health care.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Skin symptoms are important for diagnosing infections in children.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Lipid nanoparticles improve drug delivery through the skin, offering stability, controlled release, and better compatibility with skin.